Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12607000400460
Ethics application status
Approved
Date submitted
30/07/2007
Date registered
3/08/2007
Date last updated
5/01/2009
Type of registration
Prospectively registered
Titles & IDs
Public title
Asthma Severity and Therapy Monitoring by Acoustics (ASThMA)
Query!
Scientific title
Asthma Severity and Therapy Monitoring by Acoustics (ASThMA) in asthmatics
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Asthma
2198
0
Query!
Condition category
Condition code
Respiratory
2293
2293
0
0
Query!
Asthma
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This first in human device study will enrol patient from 3 different groups. Group 1 will include patients previously diagnosed with asthma using Ventolin to relieve chest tightness or shortness of breath. Group 2 will include patients referred to have a Bronchial Provocation Challenge. Group 3 will include acute asthmatics who have been admitted to the Alfred Hospital for treatment of an asthma exacerbation. Once recruited certain breathing manoeuvres will be requested of the patient while sound is introduced into their upper airways using a nasal cannula or a mouth piece. In addition to a respiratory belt to monitor respiration, a series of microphones will be placed on each patient's back and chest which will record sounds that reach their chest wall. The sound reaching the microphones will have passed through the chest wall and a part of your lung. We predict that the attenuation of sound through airways will be higher i.e. less sound will be transmitted to the microphone, when experiencing asthma symptoms. We also expect wheezes to be detected.
Query!
Intervention code [1]
1913
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
This is a first in human pilot study and there is no comparator or control being used.
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
3183
0
A correlation between airway narrowing, sound attenuation and wheeze detection.
Query!
Assessment method [1]
3183
0
Query!
Timepoint [1]
3183
0
At time of presentation to the hospital (single day trial with no extended follow-up).
Query!
Secondary outcome [1]
5309
0
Development of a Asthma Severity Index
Query!
Assessment method [1]
5309
0
Query!
Timepoint [1]
5309
0
At time of presentation to the hospital (single day trial with no extended follow-up).
Query!
Eligibility
Key inclusion criteria
Three groups of patients will be invited to participate and we aim to include between six and ten subjects in each group:1. Those with asthma, who are clinically stable with known bronchodilator reversibility on the basis of previous spirometric testing and who use inhaled Salbutamol as required.2. Those undergoing bronchial provocation testing as part of their current clinical care.Inpatients of the Alfred Hospital with an admission diagnosis of an exacerbation of asthma.3. All patients must be able to give informed consent.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
70
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Skin problems that preclude placement of the sensors with an adhesive 2. Life-threatening condition with the patient's condition being considered "unstable" or "critical" by the attending physician.3. Patient who cannot read and understand the informed consent.
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Phase 1 / Phase 2
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/10/2007
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
30
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
2456
0
Commercial sector/Industry
Query!
Name [1]
2456
0
PulmoSonix Pty Ltd
Query!
Address [1]
2456
0
336A Glenhuntly Road Elsternwick VIC 3185
Query!
Country [1]
2456
0
Australia
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
PulmoSonix Pty Ltd
Query!
Address
336A Glenhuntly Road Elsternwick VIC 3185
Query!
Country
Australia
Query!
Secondary sponsor category [1]
2228
0
None
Query!
Name [1]
2228
0
N/A
Query!
Address [1]
2228
0
Query!
Country [1]
2228
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
6362
0
Alfred Hosptial
Query!
Ethics committee address [1]
6362
0
Commercial Rd, Melbourne
Query!
Ethics committee country [1]
6362
0
Australia
Query!
Date submitted for ethics approval [1]
6362
0
13/12/2007
Query!
Approval date [1]
6362
0
13/12/2007
Query!
Ethics approval number [1]
6362
0
180/07
Query!
Summary
Brief summary
Primary Hypothesis: That wheeze detection technology and acoustic transmission methods can detect changes in sound transmission that are reflective of changes in airflow obstruction in asthma. Aims: To characterise wheeze detection technology and acoustic transmission methods in patients with asthma in a variety of clinical situations and to correlate these with conventional clinical and spirometric assessment.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
27727
0
Query!
Address
27727
0
Query!
Country
27727
0
Query!
Phone
27727
0
Query!
Fax
27727
0
Query!
Email
27727
0
Query!
Contact person for public queries
Name
11102
0
Shaun Bowden
Query!
Address
11102
0
336A Glenhuntly Road Elsternwick VIC 3185
Query!
Country
11102
0
Australia
Query!
Phone
11102
0
+61 3 95324283
Query!
Fax
11102
0
Query!
Email
11102
0
[email protected]
Query!
Contact person for scientific queries
Name
2030
0
Peter Camilleri
Query!
Address
2030
0
336A Glenhuntly Road Elsternwick VIC 3185
Query!
Country
2030
0
Australia
Query!
Phone
2030
0
+61 3 95324283
Query!
Fax
2030
0
Query!
Email
2030
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF